140 related articles for article (PubMed ID: 12771301)
1. Surgical verification of percutaneous maxacalcitol injection therapy on enlarged parathyroid glands in chronic dialysis patients.
Yamamoto H; Katoh N; Takeyama H; Ikeda M; Yokoyama K; Shigematsu T; Kawaguchi Y; Hosoya T
Nephrol Dial Transplant; 2003 Jun; 18 Suppl 3():iii50-2. PubMed ID: 12771301
[TBL] [Abstract][Full Text] [Related]
2. Long-term (3 years) prognosis of parathyroid function in chronic dialysis patients after percutaneous ethanol injection therapy guided by colour Doppler ultrasonography.
Tanaka R; Kakuta T; Fujisaki T; Tanaka S; Sakai H; Kurokawa K; Saito A
Nephrol Dial Transplant; 2003 Jun; 18 Suppl 3():iii58-61. PubMed ID: 12771303
[TBL] [Abstract][Full Text] [Related]
3. Combination therapy of intravenous maxacalcitol and percutaneous ethanol injection therapy lowers serum parathyroid hormone level and calcium x phosphorus product in secondary hyperparathyroidism.
Tanaka M; Itoh K; Matsushita K; Matsushita K; Fukagawa M
Nephron Clin Pract; 2006; 102(1):c1-7. PubMed ID: 16166800
[TBL] [Abstract][Full Text] [Related]
4. Clinical features and hyperplastic patterns of parathyroid glands in hemodialysis patients with advanced secondary hyperparathyroidism refractory to maxacalcitol treatment and required parathyroidectomy.
Tominaga Y; Matsuoka S; Sato T; Uno N; Goto N; Katayama A; Haba T;
Ther Apher Dial; 2007 Aug; 11(4):266-73. PubMed ID: 17661832
[TBL] [Abstract][Full Text] [Related]
5. Reduction of functioning parathyroid cell mass by ethanol injection in chronic dialysis patients.
Kitaoka M; Fukagawa M; Ogata E; Kurokawa K
Kidney Int; 1994 Oct; 46(4):1110-7. PubMed ID: 7861705
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of direct injection of calcitriol into the parathyroid glands in uraemic patients with moderate to severe secondary hyperparathyroidism.
Nakanishi S; Yano S; Nomura R; Tsukamoto T; Shimizu Y; Shin J; Fukagawa M
Nephrol Dial Transplant; 2003 Jun; 18 Suppl 3():iii47-9. PubMed ID: 12771300
[TBL] [Abstract][Full Text] [Related]
7. Biochemical and cellular effects of direct maxacalcitol injection into parathyroid gland in uremic rats.
Shiizaki K; Negi S; Hatamura I; Sakaguchi T; Saji F; Kunimoto K; Mizobuchi M; Imazeki I; Ooshima A; Akizawa T
J Am Soc Nephrol; 2005 Jan; 16(1):97-108. PubMed ID: 15574509
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous ethanol (PEIT) and calcitrol (PCIT) injection therapy are ineffective in treating severe secondary hyperparathyroidism.
de Barros Gueiros JE; Chammas MC; Gerhard R; da Silva Dias Boilesen CF; de Oliveira IR; Moysés RM; Jorgetti V
Nephrol Dial Transplant; 2004 Mar; 19(3):657-63. PubMed ID: 14767023
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous maxacalcitol injection therapy regresses hyperplasia of parathyroid and induces apoptosis in uremia.
Shiizaki K; Hatamura I; Negi S; Narukawa N; Mizobuchi M; Sakaguchi T; Ooshima A; Akizawa T
Kidney Int; 2003 Sep; 64(3):992-1003. PubMed ID: 12911549
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of percutaneous ethanol injection therapy (PEIT) is related to the number of parathyroid glands in haemodialysis patients with secondary hyperparathyroidism.
Koiwa F; Kakuta T; Tanaka R; Yumita S
Nephrol Dial Transplant; 2007 Feb; 22(2):522-8. PubMed ID: 17127701
[TBL] [Abstract][Full Text] [Related]
11. Intervention for recurrent secondary hyperparathyroidism from a residual parathyroid gland.
Yumita S
Nephrol Dial Transplant; 2003 Jun; 18 Suppl 3():iii62-4. PubMed ID: 12771304
[TBL] [Abstract][Full Text] [Related]
12. Calcitriol pulse therapy and histology of parathyroid glands in hemodialysis patients.
Lomonte C; Martino R; Selvaggiolo M; Bona RM; Cazzato F; Milano R; Chiarulli G; Basile C
J Nephrol; 2003; 16(5):716-20. PubMed ID: 14733419
[TBL] [Abstract][Full Text] [Related]
13. Changes in interventional treatment--from the viewpoint of percutaneous ethanol injection therapy.
Kitaoka M
Ther Apher Dial; 2008 Oct; 12 Suppl 1():S16-20. PubMed ID: 19032521
[TBL] [Abstract][Full Text] [Related]
14. [PEIT is the part of strategy for severe hyperparathyroidism in patients requiring hemodialysis].
Uemura K; Kakuta T
Clin Calcium; 2004 Sep; 14(9):88-92. PubMed ID: 15577118
[TBL] [Abstract][Full Text] [Related]
15. Successful ultrasonically guided percutaneous ethanol injection for secondary hyperparathyroidism.
Takeda S; Michigishi T; Takazakura E
Nephron; 1992; 62(1):100-3. PubMed ID: 1436272
[TBL] [Abstract][Full Text] [Related]
16. Effects of calcitriol on parathyroid function and on bone remodelling in secondary hyperparathyroidism.
Costa AF; dos Reis LM; Ribeiro MC; Moysés RM; Jorgetti V
Nephrol Dial Transplant; 2003 Apr; 18(4):743-9. PubMed ID: 12637644
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of weekly percutaneous maxacalcitol injection therapy in patients with secondary hyperparathyroidism.
Saito A; Matsumoto Y; Oyama Y; Asaka M; Yokoyama H
Ther Apher Dial; 2010 Feb; 14(1):98-103. PubMed ID: 20438525
[TBL] [Abstract][Full Text] [Related]
18. Assessment of ultrasound guided percutaneous ethanol injection and parathyroidectomy in patients with tertiary hyperparathyroidism.
Fletcher S; Kanagasundaram NS; Rayner HC; Irving HC; Fowler RC; Brownjohn AM; Turney JH; Will EJ; Davison AM
Nephrol Dial Transplant; 1998 Dec; 13(12):3111-7. PubMed ID: 9870475
[TBL] [Abstract][Full Text] [Related]
19. Percutaneous calcitriol injection therapy (PCIT) for secondary hyperparathyroidism: multicentre trial.
Kitaoka M; Onoda N; Kitamura H; Koiwa F; Tanaka M; Fukagawa M
Nephrol Dial Transplant; 2003 Jun; 18 Suppl 3():iii38-41. PubMed ID: 12771298
[TBL] [Abstract][Full Text] [Related]
20. Ultrasonographic intervention of parathyroid hyperplasia in chronic dialysis patients: a theoretical approach.
Fukagawa M; Kitaoka M; Kurokawa K
Nephrol Dial Transplant; 1996; 11 Suppl 3():125-9. PubMed ID: 8840327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
